-
TOMORROW, California lifts universal indoor mask mandate. California News
-
DHCS revises Medi-Cal RX prior authorization policy. California News
-
This Thursday, February 17, E&M Updates webinar Medicare News/ Noridian Programs
|
|
MOASC Programs - Save the Dates - All Times are Pacific
|
|
Thank you for your participation in the Virtual Presentation, “Improving Patient Collections Experience," presented by Adam Younger, MBA, Co-Founder and Chief Strategy Officer, PayGround. If you have any questions, please email Adam Younger at adam@payground.com or 812-914-1613.
MOASC has made the recording available to you by clicking the link below.
Use Passcode: %u2tgi^z
|
|
On Tuesday, February 22nd, at 10am, join Bobbi Buell’s presentation on Coding for Chronic Care: Understanding All the Nuances to 2022 Reimbursements.
|
|
February 23, 2022, MOASC presents their Lung Cancer Series webinar on the Treatment of KRAS Mutated Non-Small Cell Lung Cancer. Join Hatim Husain, MD, University of California San Diego, Jonathan Riess, M.D., University of California, Davis, and Sukhmani Padda, M.D., Cedars-Sinai Medical Center for a lively discussion. This is a great opportunity to learn from key opinion leaders and network with colleagues. Hear the latest clinical trial data, apply it to your patients, consider real-world scenarios and how to mitigate barriers to treatment. Submit your questions and cases, in advance, for collaborative discussion with colleagues and experts.
|
|
February 26, 2022 MOASC presents Spotlight On Hematology. Selected fellows and faculty, from the University of California, Irvine, will present the premier topics from their attendance at the 2021 Annual ASH Meeting. Through virtual conferencing, the presentations will promote collegial discourse among colleagues and networking among attendees.
|
|
March 26, 2022 - MOASC’s 7th Annual Oncology Summit & Research Symposium at the Hyatt Regency in Huntington Beach. This LIVE Meeting will follow a multi-tumor approach with nationally recognized speakers, which will review personalized cancer care and current clinical trials in Breast, Gastrointestinal, Genitourinary, Lung, CAR-T/Transplant and Myeloma. This will be a great opportunity to learn from experts and network with colleagues.
|
|
The Hoag Oncology Nursing Conference is virtual again this year. Word is, it is simply the best virtual oncology nursing event!
March 11-12, 2022 Hoag Oncology Nursing Conference
April 27 – May 1, 2022 Oncology Nursing Congress
|
|
UC San Diego invites you to an interactive online learning experience on Gather-ed where you can earn free CME credits and learn about Advances in Basal Cell Carcinoma at your own pace from your own computer. We think you will find it enjoyable, and the time commitment is extremely modest and flexible.
|
|
The Medical Oncology Association of Southern California cordially invites you to attend to a CME/CNE-certified, ABIM MOC-eligible live webinar entitled, Personalized Approaches to HER2-Positive Breast Cancer Treatment, held live online! This activity will provide oncology clinicians with information on the most recent treatments for HER2-positive breast cancer, expert recommendations for treatment selection and sequencing, and how to identify and treat HER2-positive patients with low HER2 expression.
|
|
Career News
Sign up now to receive the MOASC Job Flash™! Please activate your new job alert.
|
|
MOASC Clinical Trial Database is on the MOASC website at www.moasc.org
|
|
TOMORROW, Feb. 16, California lifts its universal indoor mask mandate. This will be the first time since June 15 that the Golden State has relaxed rules on moving about freely without face coverings.
|
|
DHCS has revised the Medi-Cal RX prior authorization policy effective immediately and retroactive to January 1, 2022. According to a notice issued on February 6, 2022, DHCS aims to provide a seamless beneficiary experience and minimize disruptions in patient access to prescription medications during the Medi-Cal Rx transition.
|
|
CDPH announced last week that individuals working in health care facilities now have until March 1, 2022, to get their COVID-19 booster shot. If they are not eligible for a booster by March 1, they must get their booster shot within 15 days of becoming eligible.
|
|
Hundreds of organizations have already signed up to oppose the, “Fairness for Injured Patients Act.” Proponents of the misleadingly self-proclaimed Fairness for Injured Patients Act, or Changes to Medical Malpractice Lawsuits Cap Initiative, appearing on the statewide ballot in November, would dramatically impact the cost and delivery of health care in California, but it’s not written by health experts or real-life medical practitioners. Instead it was drafted to allow a few to make millions more from filing personal injury lawsuits. If passed, the law would remove all existing caps on attorney’s fees, resulting in huge financial windfalls for trial lawyers who sue doctors, nurses, clinicians and other health providers for a living. It also creates a new process that prohibits judges from independently verifying the truthfulness of statements made by trial attorneys in the initial court filings.
|
|
The 2021-2025 state cancer plan is now available for download here.
|
|
Non-physician Practitioners (NPPs) Evaluation and Management (E/M) Services is recognized by Noridian. This article describes the CMS guidelines for performing and billing such services appropriately, along with process changes Noridian is implementing for E/M codes 99202-99215, 99221-99233, 99238, 99239.
|
|
Duplicate Remits Containing CO-97 and N111 has been resolved. Noridian identified an issue with duplicate processing for claims submitted between January 9, 2022, and January 16, 2022. Submitters may receive duplicate 277CA reports indicating a duplicate rejection. Providers may also receive remits indicating duplicate denials with the remark codes CO-97 and N111. Please disregard these remits. Providers can locate a pending and/or paid claim in the Noridian Medicare Portal (NMP) or Interactive Voice Recognition (IVR) system.
|
|
February 17, 2022. Evaluation and Management Updates webinar includes: Evaluation and Management Codes 99202-99215, AMA Errata and Technical Corrections, and Resources.
|
|
February 24, 2022. Please go to the link below to review the notice regarding an Open Public Meeting. One of the several policies being discussed is MolDX: Plasma-Based Genomic Profiling in Solid Tumors; Epidural Steroid Injections for Pain Management. This meeting will be held via teleconference only from 10:00am-1:00pm Pacific time.
|
|
CMS released proposed payment policy changes for Medicare Advantage and Part D drug programs in 2023 that will create more choices and provide affordable options for consumers that meet their unique health needs. The Calendar Year (CY) 2023 Advance Notice for Medicare Advantage (MA) and Part D plans is open to public comment for 30 days, due March 4, 2022. This year, CMS is specifically soliciting input through a health equity lens on the approach to some future potential changes.
|
|
ICD-11 is now officially in effect, for the national and international recording and reporting of grade and stage coding for cancers, cancer registration, causes of illness, death and more. Not implemented in the United States, yet, ICD-11, is entirely digital, contains some 17,000 unique codes and more than 120,000 codable terms. ICD-11 includes a coding tool and app, support for grade and stage coding for cancers, and it was specifically designed to support certifying and reporting cause of death, morbidity coding and reporting, case mix and Diagnosis-Related Grouping, among other use cases.
|
|
Affiliate Association News |
|
March 11-13, 2022, the 22nd Multidisciplinary Management of Cancers: A Case-based Approach returns to the Silverado Resort and Spa in Napa. The meeting is sponsored by the Association of Northern California Oncologists, Stanford Cancer Institute, UC Davis Comprehensive Cancer Center, and the UCSF Helen Diller Family Comprehensive Cancer Center. Registration is now open for HCP for in person and virtual attendance.
|
|
TODAY, February 15 is the DEADLINE to submit an abstract, for the 2022 ASCO Annual Meeting in Chicago on June 3-7, 2022.
|
|
Don’t miss the ONLY official event that provides synopses of the top hematology research presented at the 63rd ASH Annual Meeting & Exposition this past December. The all virtual experience this year will take place between March 16 and April 9, 2022. Registration for the Highlights of ASH in North America includes 15 prerecorded presentations, five live Q&A sessions. Call 866-828-1231 for more information.
|
|
CMS needs to hear from us and understand that the DIR fees charged by PBMs are not only outrageous, but they are also unpredictable, and non-negotiable. For years, Pharmacy Benefit Managers (PBMs) have been extracting outrageous direct and indirect remuneration (DIR) fees from pharmacies. This includes independent and retail pharmacies, as well as those associated with practices, such as cancer and urology pharmacies. DIR fees have had a devastating effect on pharmacies and patients. Since pharmacies are in the dark about how much the fees for each prescription will be until after dispensing them, they often end up losing money. In some cases, pharmacies have been forced to close. Patients in rural and underserved areas suffer the consequences of this rigged game most acutely, where one pharmacy closing could force patients to have to travel a significant distance to get their medication. The Centers for Medicare and Medicaid Services (CMS) has finally picked up the mantle, showing real interest in meaningfully regulating DIR fees. This is your chance to make your voice heard. By sharing your story about these abusive DIR fees, you can encourage CMS to act.
|
|
Have you registered for the 2022 COA Conference, yet? Save your seat. Reserve your room for a discount through February 20th. On March 17-18, oncology professionals from around the country will gather at the Gaylord Palms Hotel in Kissimmee, Florida for the best oncology conference in the country.
|
|
CURE’s sister franchise, Physician’s Education Resource (PER) has an upcoming CME opportunity. As MOASC is a partner, PER is offering 35% discounted registration for MOASC physicians to the 39th Annual Miami Breast Cancer Conference, March 3-6, 2022 at the Fontainebleau Miami Beach, Miami Beach, FL. This event will be Live, In-person & Virtual
Program chairs: Patrick L. Borden, MD, Debu Tripathy, MD, Hope S. Rugo, MD, FASCO.
|
|
AstraZeneca informed MOASC that the FDA has issued an Emergency Use Authorization (EUA) for the emergency use of the unapproved product EVUSHELDTM (tixagevimab co-packaged with cilgavimab) for the pre-exposure prophylaxis of coronavirus disease 2019 (COVID-19) in adults and pediatric individuals (12 years of age and older weighing at least 40 kg).
|
|
The Medical Oncology Association of Southern California (MOASC) is a leading oncology society that advances and protects the ability of cancer patients to obtain, and the ability of the oncology physicians to provide, optimal cancer care. The material contained in the California Oncology Weekly is intended as general information for MOASC members. Because diagnostic, treatment, contracting, coding, and billing decisions should be made on a case-by-case basis, any such information contained in the California Oncology Weekly may not apply in any given situation. Members are encouraged to contact their own consultants or advisors to obtain specific advice on matters relating to contracting, coding, and billing. The information contained in California Oncology Weekly should not be used as a substitute for such advice. This publication provides a summary of regulations affecting oncology and its business practices. Reading this newsletter does not substitute for understanding regulations and verifying the validity of every claim. This information is time-sensitive and is subject to change. MOASC accepts no liability for any statements or articles herein. CPT codes are owned and trademarked by the American Medical Association. All Rights Reserved.
|
|
|
|
|
|
|
